1nessAgency Insights

The FDA's approval covers generic baloxavir marboxil tablets for patients five years of age and older, applicable to both treatment of acute uncomplicated influenza (when symptoms begin within 48 hours) and post-exposure prophylaxis following known exposure to an infected individual [1]. The drug's

Boston Children's, one of the most research-intensive pediatric hospitals in the United States, achieved these results through an enterprise partnership with OpenAI, deploying large language model capabilities across clinical documentation, administrative workflows, and operational processes. [1] Wh

Moody's has flagged the approaching patent cliff as a structural inflection point for hospital finances [1]. The mechanism is straightforward: when blockbuster branded drugs lose exclusivity, generic and biosimilar manufacturers enter the market, and institutional buyers , hospitals, health systems,

The Centers for Medicare & Medicaid Services has finalized a federal framework enabling states to impose work requirements on Medicaid enrollees , a structural shift that carries direct consequences for patient volume, service-line revenue, and community health marketing strategies at hospitals and

Healthcare systems face a collision: hospital cash reserves are under scrutiny at the exact moment patient acquisition channels are evaporating. Days cash on hand—the number of days a health system can operate using only its cash reserves—has become a critical metric as 35 major health systems face

Albany Med Health System's exploration of an affiliation with Ellis Medicine represents the continuation of a merger trend that reshrites the rules for patient acquisition across regional markets. For healthcare marketers, these transactions create immediate headwinds: duplicate service lines, overl

Health systems spent the last decade connecting genomic data to EHRs. The next competitive battlefield is making that data discoverable when patients ask AI where to go for precision medicine. The organizations that close the "exome gap" — the chasm between having genomic capabilities and being reco

Salesforce signed a definitive agreement on June 1, 2026 to acquire Contentful, the composable content platform, in a move that exposes the infrastructure gap separating static healthcare marketing from AI-driven personalization . The transaction, expected to close in Salesforce's third quarter of f

The merger of Rialtic, an Atlanta-based cloud platform for payment accuracy founded in 2020, and Exponential AI, whose real-time decision intelligence platform Enso is already deployed across leading U.S. health plans and systems, creates one of the most comprehensive claim-lifecycle technology suit

A compliance consultant from Tennessee followed her telehealth provider's dosing instructions precisely. Within 24 hours, she was hospitalized with a GLP-1 overdose — the prescribed dose was nearly nine times what patients typically receive for their first injection. The January 2026 incident highli

Medical practices are moving faster than health systems on AI adoption, and the gap is widening. Approximately 12.5% of medical practices have deployed AI receptionists as of May 2026, with adoption concentrated among practices with 4 to 10 providers, according to The Algorithm's latest research . S

Advocate Health has launched an artificial intelligence partnership focused on clinical trial matching in 2026, marking a strategic shift in how large health systems position themselves in the competitive landscape of specialty care and patient retention. For healthcare marketers, this development r

Roche's May 2026 definitive merger agreement to acquire PathAI marks the largest consolidation of AI-driven diagnostic capabilities inside a single global diagnostics portfolio in recent memory , and it reshapes the competitive terrain for every health system, oncology practice, and diagnostic lab t

A UC Berkeley spin-out just secured $11.6 million in seed funding to build something healthcare has never seen: an AI model that learns not from medical textbooks, but from how clinicians actually make decisions . Knit Health emerged from stealth in May 2026 with a Large Clinical Behavior Model (LCB

Penn Medicine, one of the country's most recognized academic health systems, is moving forward with the deployment of AI-powered clinical agents , autonomous or semi-autonomous software systems capable of performing clinical reasoning tasks, triaging patient needs, drafting care summaries, and coord

Reddit CEO Steve Huffman declared in May 2026 that large language models "would not exist as we know them" without Reddit's user-generated content, calling the platform's data "modern oil" for artificial intelligence . Healthcare marketers should pay attention: The battle over conversational data ha

A potential gene therapy for lifelong cholesterol management just moved from theoretical to probable, and the implications reach far beyond cardiology wards. Healthcare marketers face a category disruption that will reshape patient acquisition funnels, lifetime value calculations, and the entire pre

The FDA's April 30, 2026 proposal to remove semaglutide, tirzepatide, and liraglutide from the 503B outsourcing facility bulks list marks the most consequential regulatory shift in weight management marketing since these drugs entered the mainstream. For the clinics, telehealth platforms, and med sp

Oura's move toward the public markets arrives as the wearable health device sector accelerates its pivot from lifestyle accessory to clinical tool. The company has pursued partnerships with health systems and researchers to validate its biometric data , heart rate variability, body temperature, resp

On April 30, 2026, the FDA approved Auvelity (dextromethorphan hydrobromide and bupropion hydrochloride) for a new indication: treating agitation associated with Alzheimer's disease dementia in adults [1]. The approval is a first of its kind , no non-antipsychotic drug has ever carried this indicati

Gilead Sciences secured a rare commercial advantage on May 22, 2026, when the FDA approved Hepcludex (bulevirtide-gmod) as the first treatment for chronic hepatitis delta virus infection in adults—ending a decades-long therapeutic drought for a disease that accelerates liver failure faster than hepa

Tennessee Governor Bill Lee signed the Freedom, Access and Integrity in Registered Pharmacy Act into law in May 2026, making the state the second in the country to prohibit pharmacy benefit managers from owning or operating pharmacies. [1] The law hands CVS Health , which operates both the Caremark

Quorum CEO Chris Harrison told Becker's Hospital Review that the transaction is expected to close in fall 2026, pending regulatory approval, and will enable the company to operate under significantly reduced debt leverage while redirecting free cash flow into operations [1]. The system plans to depl

During May 20, 2026 budget hearings before the Senate Veterans' Affairs Committee and a House Appropriations subcommittee, VA Secretary Doug Collins told lawmakers that the EHR rollout , previously halted and heavily criticized , has turned a corner [1]. VA CFO Richard Topping put concrete numbers t

The Centers for Medicare & Medicaid Services proposed a rule on May 20, 2026, that would cap state-directed Medicaid payments and align them with Medicare rates , a structural change projected to strip more than $775 billion from Medicaid spending over the next decade, including $510 billion in fede